INS and diabetic kidney disease: Additionally, DKD progressors had a higher proportion of hypertension (58.4% vs. 46.9%, P < 0.001), insulin use (43.1% vs. 31.0%, P < 0.001), and ACEI/ARB use (22.2% vs. 18.1%, P = 0.017) and a lower usage rate of SGLT2is/GLP-1RAs (8.7% vs. 11.7%, P = 0.026).